Xeerarka hadda jira waxay u ogolyihiin baaritaanka hore
Diagnosing sclerosis multiple (MS) waxay noqon kartaa mid adag oo inta badan soconaya. Tani waa sababta oo ah ma jiraan wax calaamado ah ama baaritaano shaybaadh ah kaas oo, isaga oo keli ah, go'aansada haddii qofku leeyahay MS.
Ereygan oo leh sclerosis badanaa lafteedu waxay sharraxaysaa cudur keena meelo badan oo dhaawac maskaxeed ah (markaa, erayga " sclerosis " macnaheedu "scarring" ama "adag").
Sidaa oo kale, ma tilmaami kartid hal dhacdo ama tijaabo si aad si cad u sheegtid in qofku leeyahay MS.
Iyadoo la sheegayo, xeerarka cusubi waxay si weyn u abaabuleen geeddi-socodka, taas oo noo ogolaaneysa in aan keenno baadhitaan qeexan waqti gaaban marka la eego muuqaalka kowaad ee calaamadaha.
Horumarka MS
Cudurka 'Multiple Sclerosis' waa cudur isdaba-kicin ah oo ka yimaada difaaca jirka kaas oo sababa waxyeelo gaarsiinta daboolka difaaca jirka unugyada (oo loo yaqaan ' myelin bury' ).
Dhibaatadani, oo loo yaqaano demyelination, waxay carqaladeyn kartaa dareemayaasha dareenka u dhexeeya unugyada waxayna horseedi karaan nabarada maskaxda iyo / ama xudunta lafdhabarta. Sameynta iyo faafidda dhaawacyadani waxay kicin kartaa calaamado jireed iyo garasho oo ku kala duwan meesha meesha uu ku yaalo burburka.
Cudurka dabiiciga ah ee cudurka dabiiciga ah (CIS) waa erey loo isticmaalo tilmaamidda calaamadaha koowaad ee MS ee soconaya ugu yaraan 24 saacadood waxaana la socda calaamadaha caabuq iyo / ama demiyelin.
CIS waxaa loo kala saari karaa mid ka mid ah laba arrimood:
- Xaalad monofocal oo ah calaamad muujinaysa hal cilad
- Meelo badan oo kala duwan oo calaamado ah oo ka badan hal calaamadood ayaa sabab u ah dhaawacyo meelo kala duwan ah
Shuruudaha Xaadirka ah ee Baaritaanka
Inkasta oo ay u muuqato in ay macquul tahay in la ogaado in dhacdooyinka kala duwan ee CIS ay ku filan tahay in lagu ogaado MS-la siiyo caddaymaha sababaha iyo calaamadaha - xaqiiqada fudud waxay tahay in boqolkiiba 15 dadka dadka qaba CIS ayan waligood tegin horumarinta MS.
Dhab ahaan ma hubno sababta ay taasi u tahay, laakiin waxa ay noo sheegeyso waa in ogaanshaha qeexan ee kaliya lagu ogaan karo cudurka ayaa lagu muujiyay inuu yahay horumar
Marka la eego xeerarka la cusbooneysiiyay sannadkii 2010, MS maanta ayaa lagu ogaan karaa iyada oo ku saleysan shuruudaha soo socda:
- Laba ama in ka badan oo weeraro ah (oo soconaya ugu yaraan 24 saacadood oo kala-gooshta ugu yaraan 30 maalmood) iyo laba laf-dhabarka oo ah baaritaanka MRI
- Laba ama wax ka badan oo weerar ah, hal nabar, iyo caddaynta in dhaawacyo cusub ay bilaabayaan inay sameeyaan qaybo kala duwan oo maskaxda ah iyo / ama xudunta lafdhabarta (oo loo yaqaan "faafinta booska")
- Mid ka mid ah weerarka, laba ama kabadan, iyo caddaynta in dhaawacyo cusub ay bilaabeen inay sameeyaan tan iyo MRI-da ugu dambeeyey (oo loo yaqaan "faafinta waqtiga")
- Hal weerar, hal bare, iyo caddaynta faafinta boosaska iyo waqtiga
- Astaamaha calaamadaha ama dhaawacyada iyo faafinta boosaska faafinta (oo ay xaqiijiyeen labadaba MRI ama lafdhabarta)
Xeerarka ayaa ka gudbaya qaar badan oo ka mid ah cilladaha hore ee shuruudaha hore (kuwaas oo ah in ay sugaan dib u soo noqosho badan kahor intaan la samayn baaritaan). Inkasta oo tilmaan-bixiyeyaashu aysan weli ogolaanin in lagu ogaado hal weerarka, waxay si weyn u gaabinayaan geeddi-socodka. Halkii ay sugi lahayd weerar kale, dhakhaatiirtu waxay hadda dalban karaan MRI labaad saddex bilood.
Haddii ay jirto caddaynta xanuuno dheeraad ah, waxay badanaa ku qancin kartaa qeexidda "faafinta waqtiga" ama "faafinta meel."
Muhiimadda Early Diagnosis
Cilmi-baarista hore waxay leedahay faa'iidooyinkeeda qaabka daaweynta hore . Cilmi-baarisyada intooda badani waxay si adag u soo jeedinayaan in daaweynta hore ay si weyn u yareeyn karto tirada soo noqoshada qofka uu la kulmi karo iyo sidoo kale khatarta naafanimada muddada gaaban.
Saynisyahanno, si kastaba ha ahaatee, weli ma ogaanin haddii daaweynta hore ay kor u qaadi doonto natiijada muddada fog 10 ama ka badan sannadka. Cilmi-baarista mustaqbalka waxay rajeyneysaa in ay ka jawaabto su'aalahan iyada oo tiknoolijiyada aqoonsiga ay sii wadi doonaan horumarinta.
> Ilo:
> Polman, C .; Reingold, S .; Banwell, B. et al. "Shuruudaha aqoonsiga ee sclerosis badan: 2010 Abaabulida shuruudaha McDonald." Annals of Neurology. 2011; 69 (2): 292-302.